DXS International Unveils Solid 2025 Final Results
🕓 Estimated Reading Time: 5 minutes Overview London, UK — DXS International plc (AQSE: DXSP), a leading provider of clinical decision support and medical information systems, has announced its DXS International final results for the financial year ended April 30, 2025, revealing a period of robust growth and strategic advancement. The company reported a significant uplift in both revenue and profitability, underscoring the increasing demand for its innovative healthcare technology solutions amidst the ongoing digital transformation of health services globally. According to the official announcement released on October 31, 2025, DXS International saw its revenue climb to £12.5 million, marking a 15% increase compared to the previous fiscal year, while profit before tax rose by an impressive 20% to £1.8 million. Background & Context DXS International operates at the forefront of digital health, providing vital software tools designed to enhance clinical workflow, improve patient ca...